BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11201801)

  • 1. Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report.
    Mamikoglu B; Mamikoglu O
    Ann Otol Rhinol Laryngol; 2001 Jan; 110(1):102. PubMed ID: 11201801
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report.
    Ress BD; Gross EM
    Ann Otol Rhinol Laryngol; 2000 Apr; 109(4):435-7. PubMed ID: 10778901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorineural hearing loss as a probable serious adverse drug reaction associated with low-dose oral azithromycin.
    Mick P; Westerberg BD
    J Otolaryngol; 2007 Oct; 36(5):257-63. PubMed ID: 17963663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin-induced hearing loss.
    Lo SH; Kotabe S; Mitsunaga L
    Am J Health Syst Pharm; 1999 Feb; 56(4):380-3. PubMed ID: 10690220
    [No Abstract]   [Full Text] [Related]  

  • 5. Azithromycin and Sensorineural Hearing Loss in Adults: A Retrospective Cohort Study.
    Alrwisan A; Antonelli PJ; Brumback BA; Wei YJ; Winterstein AG
    Otol Neurotol; 2018 Sep; 39(8):957-963. PubMed ID: 29965935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxicity with azithromycin.
    Wallace MR; Miller LK; Nguyen MT; Shields AR
    Lancet; 1994 Jan; 343(8891):241. PubMed ID: 7904701
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible sensorineural hearing loss due to clarithromycin.
    Coulston J; Balaratnam N
    Postgrad Med J; 2005 Jan; 81(951):58-9. PubMed ID: 15640431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin induced reversible sensorineural hearing loss.
    Hajiioannou JK; Florou V; Kousoulis P; Fragkos M; Moshovakis E
    B-ENT; 2011; 7(2):127-30. PubMed ID: 21838098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensorineural hearing loss associated with intrathecal vancomycin.
    Klibanov OM; Filicko JE; DeSimone JA; Tice DS
    Ann Pharmacother; 2003 Jan; 37(1):61-5. PubMed ID: 12503934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ototoxicity exemplified by aminoglycosides and cisplatin: is there a specific antidote].
    Dieler R; Shehata-Dieler WE
    HNO; 1994 Sep; 42(9):525-8. PubMed ID: 7989223
    [No Abstract]   [Full Text] [Related]  

  • 11. "Sensorineural deafness in Tanzanian children--is ototoxicity a significant cause? A pilot study" by Freeland et al. [Int. J. Pediatr. Otorhinolaryngol. 74 (2) (2010) 516-519].
    Freeland A; Jones J; Mohammed N
    Int J Pediatr Otorhinolaryngol; 2010 Dec; 74(12):1458. PubMed ID: 20884066
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of ototoxicity of aminoglycosides "locked" to prevent hemodialysis catheter-related infections.
    Saxena AK
    Hemodial Int; 2006 Jan; 10(1):94. PubMed ID: 16441834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ototoxicity of aminoglycoside antibiotics: an alternative in sight?].
    Ruppersberg JP
    HNO; 1997 Mar; 45(3):111-2. PubMed ID: 9417430
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cochlear-vestibular ototoxicity by gentamicin. Report of a case and literature review].
    Pino Rivero V; Marcos García M; Keituqwa Yáñez T; González Palomino A; Trinidad Ruiz G; Pardo Romero G; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2004; 31(6):531-7. PubMed ID: 15663084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity after use of neomycin eardrops is unrelated to A1555G point mutation in mitochondrial DNA.
    Yamasoba T; Tsukuda K
    J Laryngol Otol; 2004 Jul; 118(7):546-50. PubMed ID: 15318963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous azithromycin-induced ototoxicity.
    Bizjak ED; Haug MT; Schilz RJ; Sarodia BD; Dresing JM
    Pharmacotherapy; 1999 Feb; 19(2):245-8. PubMed ID: 10030778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring drug ototoxicity with distortion products].
    Orts Alborch M; Morant Ventura A; García Callejo J; Ferrer Baixauli F; Martínez Beneito MP; Marco Algarra J
    Acta Otorrinolaringol Esp; 2000; 51(5):387-95. PubMed ID: 11000679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside ototoxicity.
    Zheng Y; Schachern PA; Sone M; Papapella MM
    Otol Neurotol; 2001 Mar; 22(2):266-8. PubMed ID: 11300281
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology of furosemide ototoxicity.
    Rybak LP
    J Otolaryngol; 1982 Apr; 11(2):127-33. PubMed ID: 7042998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: 'Sensorineuronal deafness in Tanzanian children--is ototoxicity a significant cause? A pilot study'.
    Schmutzhard J; Kositz CH; Lackner P; Glueckert R; Schmutzhard E; Schrott-Fischer A; Riechelmann H
    Int J Pediatr Otorhinolaryngol; 2010 Dec; 74(12):1458-9. PubMed ID: 20863579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.